ID: MRFR/MED/0191-HCR | August 2022 | Region: Bric | 50 Pages
1 REPORT PROLOGUE
2 MARKET INTRODUCTION
2.1 INTRODUCTION
2.2 SCOPE OF STUDY
2.3 RESEARCH OBJECTIVE
2.4 ASSUMPTIONS & LIMITATIONS
2.4.1 ASSUMPTIONS
2.4.2 LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
4 MARKET DYNAMICS
4.1 DRIVERS
4.1.1 EXTENSIVE R&D IN MEDICAL DEVICES
4.1.2 INCREASING GERIATRIC POPULATION IN EUROPE
4.1.3 INCREASED PREVALENCE SMOKING AND OTHER RESPIRATORY DISEASES
4.2 RESTRAINTS
4.2.1 HIGH COST ASSOCIATED WITH THE APPLICATION OF RESPIRATORY THERAPEUTIC DEVICES AND TECHNOLOGY
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF RIVALRY
5.2 SUPPLY CHAIN ANALYSIS
6 ASIA PACIFIC RESPIRATORY THERAPEUTIC DEVICES MARKET, BY DEVICES
6.1 NEBULIZERS
6.1.1 MECHANICAL NEBULIZER
6.1.1.1 SOFT MIST INHALER
6.1.1.2 HUMAN POWERED NEBULIZER
6.1.2 ELECTRICAL NEBULIZER
6.1.2.1 JET NEBULIZER
6.1.2.2 ULTRASONIC WAVE NEBULIZER
6.1.2.3 OTHER
6.2 HUMIDIFIERS
6.2.1 BUBBLE HUMIDIFIERS
6.2.2 ELECTRICAL HUMIDIFIER
6.3 OXYGEN CONCENTRATORS
6.3.1 CONTINUES OXYGEN CONCENTRATORS
6.3.2 PORTABLE OXYGEN CONCENTRATORS
6.4 VENTILATORS
6.4.1 VOLUME-CYCLED VENTILATORS.
6.4.2 PRESSURE-CYCLED VENTILATORS
6.4.3 FLOW-CYCLED VENTILATORS
6.4.4 OTHER
6.5 GAS ANALYZERS
6.6 CAPNOGRAPHS
6.7 POSITIVE AIRWAY PRESSURE (PAP)
6.7.1 CONTINUOUS POSITIVE AIRWAY PRESSURE
6.7.2 AUTOMATIC POSITIVE AIRWAY PRESSURE
6.7.3 OTHER
6.8 MASKS
6.8.1 NASAL MASK
6.8.2 FULL FACE MASK
6.8.3 OTHER
6.9 OTHERS
7 ASIA PACIFIC RESPIRATORY THERAPEUTIC DEVICES MARKET, BY TECHNOLOGY
7.1 ELECTROSTATIC FILTRATION
7.2 HEPA FILTER
7.3 HOLLOW FIBER FILTRATION
7.4 MICROSPHERE SEPARATION
7.5 OTHERS
8 ASIA PACIFIC RESPIRATORY THERAPEUTIC DEVICES MARKET, BY END USER
8.1 HOSPITAL
8.2 HOMECARE
9 ASIA PACIFIC RESPIRATORY THERAPEUTIC DEVICES MARKET, BY REGION
9.1 INTRODUCTION
9.1.1 ASIA
9.1.1.1 JAPAN
9.1.1.2 CHINA
9.1.1.3 INDIA
9.1.1.4 AUSTRALIA
9.1.1.5 REPUBLIC OF KOREA
9.1.1.5 REST OF ASIA-PACIFIC
10 COMPETITIVE LANDSCAPE
10.1 PRICING OF RESPIRATORY THERAPEUTIC DEVICES
10.2 PRODUCTION CAPACITY OF MAJOR PLAYERS
11 COMPANY PROFILE
11.1 MASIMO CORPORATION
11.1.1 OVERVIEW
11.1.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.1.3 FINANCIAL UPDATES
11.1.4 KEY DEVELOPMENTS
11.2 BECTON, DICKINSON AND COMPANY
11.2.1 OVERVIEW
11.2.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.2.3 FINANCIAL UPDATES
11.2.4 KEY DEVELOPMENTS
11.3 KONINKLIJKE PHILIPS
11.3.1 OVERVIEW
11.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.3.3 FINANCIAL UPDATES
11.3.4 KEY DEVELOPMENTS
11.4 TERUMA MEDICAL CORPORATION
11.4.1 OVERVIEW
11.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.4.3 FINANCIAL UPDATES
11.4.4 KEY DEVELOPMENTS
11.5 HAMILTON MEDICAL AG
11.5.1 OVERVIEW
11.5.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.5.3 FINANCIAL UPDATES
11.5.4 KEY DEVELOPMENTS
11.6 PORTEX DIVISION OF SMITH INDUSTRIES MEDICAL SYSTEM
11.6.1 OVERVIEW
11.6.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.6.3 FINANCIAL UPDATES
11.6.4 KEY DEVELOPMENTS
11.7 OTHERS
12. BIBLIOGRAPHY
Market Synopsis of Respiratory Therapeutic Devices Market:
Market Scenario:
Respiratory therapeutic devices are the instrument or the devices used to treat the respiratory diseases. These therapeutic devices are used in the treatment of chronic and acute respiratory diseases such as Asthma, COPD, tuberculosis and many more. Respiratory devices market is continuously growing in Asia Pacific region due to increasing number of cases of respiratory problems and is expected to growing with a healthy rate of ~9.5%. Increasing population has increased the pollution and different air borne disease which has serve as a driving factor for the increase in the respiratory therapeutic devices market.
Different types of respiratory therapeutic devices are present in the market. Positive airway pressure (PAP) is the most famous and widely used device in the Asia Pacific region. While high cost of the product and lack of awareness about management of respiratory diseases can hamper the growth of the market.
Study Objectives of Asia Pacific Respiratory Therapeutic Devices Market:
Regional Analysis
On regional basis Asia Pacific is segmented into Japan, China, India, Australia, Republic of Korea and Rest of Asia-Pacific. Increasing prevalence of diseases has increased the respiratory therapeutic device market. According to COPD foundation, it was estimated that 6.2% of total Asia Pacific population is suffering from COPD. And COPD will be the fifth leading cause for death till 2020. India has 30 million COPD patient while 8% of total china population is suffering from COPD due to increasing pollution.
Segments:
Asia Pacific Respiratory Therapeutic Devices market has been segmented on the basis of-
Intended Audience